(Q40122136)

17 September 2017

Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB. (English)

1 reference

malignant peripheral nerve sheath tumor

17 September 2017

0 references

imatinib

1 reference

adult malignant schwannoma

inferred from title

1 reference

Mikiko Aoki

1

1 reference

17 September 2017

Kazuki Nabeshima

2

1 reference

17 September 2017

Kaori Koga

3

1 reference

17 September 2017

Makoto Hamasaki

4

1 reference

17 September 2017

Junji Suzumiya

5

1 reference

17 September 2017

Kazuo Tamura

6

1 reference

17 September 2017

Hiroshi Iwasaki

7

1 reference

17 September 2017

11 June 2007

1 reference

17 September 2017

Laboratory Investigation

1 reference

17 September 2017

87

1 reference

17 September 2017

767-779

1 reference

17 September 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700591

17 September 2017

0 references

cites work

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Malignant peripheral nerve sheath tumor: analysis of treatment outcome

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Malignant peripheral nerve sheath tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Expression of platelet-derived growth factor (PDGF) and PDGF alpha- and beta-receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Mitogen accumulation in von Recklinghausen neurofibromatosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Growth factors: Mechanism of action and relation to oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Two classes of PDGF receptor recognize different isoforms of PDGF

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Novel PDGF family members: PDGF-C and PDGF-D.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Nonselective actions of herbimycin A

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Imatinib mesylate--a new oral targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Imatinib-induced regression of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Cytogenetic findings in malignant peripheral nerve sheath tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Cytogenetic characterization of six malignant peripheral nerve sheath tumors: comparison of karyotyping and comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700591

7 January 2021

10.1038/LABINVEST.3700591

Identifiers

DOI

1 reference

17 September 2017

1 reference